Show simple item record

dc.contributor.authorAndreyev, HJNen_US
dc.contributor.authorMuls, ACen_US
dc.contributor.authorShaw, Cen_US
dc.contributor.authorJackson, RRen_US
dc.contributor.authorGee, Cen_US
dc.contributor.authorVyoral, Sen_US
dc.contributor.authorDavies, ARen_US
dc.coverage.spatialEnglanden_US
dc.date.accessioned2018-02-19T09:49:40Z
dc.date.issued2017-10en_US
dc.identifierhttps://www.ncbi.nlm.nih.gov/pubmed/29067157en_US
dc.identifierflgastro-2016-100714en_US
dc.identifier.citationFrontline Gastroenterol, 2017, 8 (4), pp. 295 - 323en_US
dc.identifier.issn2041-4137en_US
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1239
dc.identifier.doi10.1136/flgastro-2016-100714en_US
dc.description.abstractBACKGROUND: Guidance: the practical management of the gastrointestinal symptoms of pelvic radiation disease was published in 2014 for a multidisciplinary audience. Following this, a companion guide to managing upper gastrointestinal (GI) consequences was developed. AIMS: The development and peer review of an algorithm which could be accessible to all types of clinicians working with patients experiencing upper GI symptoms following cancer treatment. METHODS: Experts who manage patients with upper GI symptoms were asked to review the guide, rating each section for agreement with the recommended measures and suggesting amendments if necessary. Specific comments were discussed and incorporated as appropriate, and this process was repeated for a second round of review. RESULTS: 21 gastroenterologists, 11 upper GI surgeons, 9 specialist dietitians, 8 clinical nurse specialists, 5 clinical oncologists, 3 medical oncologists and 4 others participated in the review. Consensus (defined prospectively as 60% or more panellists selecting 'strongly agree' or 'agree') was reached for all of the original 31 sections in the guide, with a median of 90%. 85% of panellists agreed that the guide was acceptable for publication or acceptable with minor revisions. 56 of the original 61 panellists participated in round 2. 93% agreed it was acceptable for publication after the first revision. Further minor amendments were made in response to round 2. CONCLUSIONS: Feedback from the panel of experts developed the guide with improvement of occasional algorithmic steps, a more user-friendly layout, clearer time frames for referral to other teams and addition of procedures to the appendix.en_US
dc.format.extent295 - 323en_US
dc.languageengen_US
dc.language.isoengen_US
dc.subjectGASTRIC CANCERen_US
dc.subjectOESOPHAGEAL CANCERen_US
dc.subjectPANCREATIC CANCERen_US
dc.subjectQUALITY OF LIFEen_US
dc.titleGuide to managing persistent upper gastrointestinal symptoms during and after treatment for cancer.en_US
dc.typeJournal Article
dcterms.dateAccepted2016-07-18en_US
rioxxterms.versionofrecord10.1136/flgastro-2016-100714en_US
rioxxterms.licenseref.startdate2017-10en_US
rioxxterms.typeJournal Article/Reviewen_US
dc.relation.isPartOfFrontline Gastroenterolen_US
pubs.issue4en_US
pubs.notesNot knownen_US
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublisheden_US
pubs.volume8en_US
pubs.embargo.termsNot knownen_US
dc.contributor.icrauthorMarsden,en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record